[急性髓性白血病与中枢神经系统的参与成功地用吉尔特利尼布治疗]
Gentaro Koyama1, Takeharu Kawaguchi1, Takumi Sato1
1Department of Hematology, Chiba Rosai Hospital.
概括
这项案例研究强调了一名耐火性急性髓性白血病患者,该患者患有中枢神经系统白血病. 口服吉尔特利尼布有效治疗中枢神经系统白血病并实现缓解,这表明其可能涉及中枢神经系统.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 神经瘤学神经瘤学
背景情况:
- 69岁妇女的超白细胞瘤导致了急性髓性白血病 (AML) 的诊断.
- 使用CAG疗法 (阿克拉鲁比辛,赛塔拉宾,菲尔格拉斯蒂姆) 的初始诱导疗法被证明是不耐药的.
- 该患者患有四肢,脑脊液 (CSF) 中的爆发升高,表明中枢神经系统 (CNS) 白血病.
研究的目的:
- 报告一种具有中枢神经系统参与的耐火性AML病例.
- 评估吉尔特利尼布在治疗中枢神经系统白血病中的疗效,特别是在FLT3-ITD突变的背景下.
- 评估吉尔特里尼布透中枢神经系统的潜力.
主要方法:
- 标准的诱导化疗 (CAG疗法) 接着是内化疗.
- 用口服吉尔特利尼布治疗FLT3-ITD阳性AML.
- 监测CSF爆发和神经状态.
主要成果:
- 内化疗最初减少了CSF爆发,但由于严重的粘膜炎而受到限制.
- 口服吉尔特利尼布治疗导致了血液学完全缓解.
- 神经症状消失了,CSF在6个多月内没有爆发.
结论:
- 吉尔特里尼布在治疗FLT3-ITD阳性AML的患者中,在治疗中枢神经系统白血病方面表现出有效性.
- 这一案例支持吉尔特里尼布潜力透中枢神经系统并管理勒普托门关节疾病.
- 用吉尔特利尼布向治疗为中枢神经系统参与的AML患者提供了一个有前途的选择.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
1.3K
12:52Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
Published on: November 28, 2015
15.8K
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
160
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
160
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K